about
Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type IIExogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?Two mutations in surfactant protein C gene associated with neonatal respiratory distressSurfactant protein B gene polymorphisms is associated with risk of bronchopulmonary dysplasia in Chinese Han populationDifferential susceptibility of transgenic mice expressing human surfactant protein B genetic variants to Pseudomonas aeruginosa induced pneumoniaGenetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injuryDelivery and performance of surfactant replacement therapies to treat pulmonary disorders.Candidate gene analysis of the surfactant protein D gene in pediatric diffuse lung disease.Large ABCA3 and SFTPC deletions resulting in lung disease.Childhood interstitial lung disease due to surfactant protein C deficiency: frequent use and costs of hospital services for a single case in Australia.Lung ischemia reperfusion injury: a bench-to-bedside review.Interstitial lung disease in infants: new classification system, imaging technique, clinical presentation and imaging findings.Children's Interstitial and Diffuse Lung Disease. Progress and Future Horizons.Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate.Lung Transplantation for FLNA-Associated Progressive Lung Disease.Motifs within the CA-repeat-rich region of Surfactant Protein B (SFTPB) intron 4 differentially affect mRNA splicing.Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology.Chronic ventilation in infants with surfactant protein C mutations: an alternative to lung transplantation.Genetic testing in children with surfactant dysfunction.Association of surfactant protein B gene polymorphisms (C/A-18, C/T1580, intron 4 and A/G9306) and haplotypes with bronchopulmonary dysplasia in chinese han population.Pbx1 activates Fgf10 in the mesenchyme of developing lungs.Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome.The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.Regulation of p53-mediated changes in the uPA-fibrinolytic system and in lung injury by loss of surfactant protein C expression in alveolar epithelial cells.
P2860
Q28729156-72BB29D1-0494-4DD2-8568-40B6806F52D7Q35013615-1ADA299C-8C1E-42C4-AF56-F4ADA5EEDF50Q35590987-DCF1C89D-D0BD-4020-A36A-E6472D0643C3Q35632237-0AABF6B3-065A-4FFE-BDFC-A64027860D66Q36421302-F7682828-7355-4408-92B8-D087E3FE6398Q36687847-4C95492C-3873-4688-89CA-3EAB94250C4BQ37341712-6D4ED596-0587-45FB-BF26-633B76D66986Q37354865-97811F44-5DE6-4AC2-A936-FF5D4B1E4D62Q37651719-EE855696-3D9F-445E-BE5D-1480FEEDB810Q37715117-ABBC1878-C720-41AD-ADCF-C52BDD08D938Q38050047-467373A0-D5C8-4A59-926D-1CC06A02075DQ38066362-F0DBDD60-32B6-419C-AD1D-5B5FE4BD8A53Q38594383-3D8C23C0-6B3F-4FE8-981B-4BE479AF82E6Q38897042-423721D2-1FD6-456D-9718-47C8B21FB4EBQ39273334-11BE74F2-AB12-4E3E-AD9C-A6C415F2F95FQ40787204-33FAD8F8-9736-46D7-B2CE-5A61DC0B8E9BQ42400570-70642BB8-394F-4D9F-95CA-2213F92F0645Q42413050-164DB63C-D953-4DB6-A976-46D9554B803BQ43440530-EF4D4835-3E89-4610-B4D9-9894BAF85A32Q43594892-3692B625-23BF-4C3B-88DA-9BE497DD4FB7Q46427248-26C84A05-AA11-4557-A3F8-9F29506A35C0Q47278982-271B0D1A-E7E0-416C-AAB1-08D3EB7C96D4Q50146324-FC29585E-A11B-48B6-81D9-BC6FA6B05D8FQ51068413-AC43FFBB-D018-4465-B490-E88C0FCCBD07
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Surfactant dysfunction.
@ast
Surfactant dysfunction.
@en
type
label
Surfactant dysfunction.
@ast
Surfactant dysfunction.
@en
prefLabel
Surfactant dysfunction.
@ast
Surfactant dysfunction.
@en
P2860
P1476
Surfactant dysfunction.
@en
P2093
Lawrence M Nogee
W Adam Gower
P2860
P304
P356
10.1016/J.PRRV.2011.01.005
P577
2011-03-05T00:00:00Z